Chinese vitamin C makers off the hook for U.S. antitrust violations
Oct 19, 2016
Following a dismissal by a U.S. appeals court of a $147 million price-fixing judgment, Chinese lawyers say that the my-government-made-me-do-it antitrust defense may not work next time for PRC companies
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
Last month, a three-judge panel of the U.S. Court of Appeals for the Second Circuit vacateda $147 million lower court verdict and freed a Chinese pharmaceutical maker from U.S. antitrust liability for price-fixing on the basis of international comity.
This premium content is reserved for China Law & Practice Subscribers.
Unlimited access to Chinalawandpractice.com site and digital newsletters
5 free articles across the ALM subscription network every 30 days
Exclusive discounts on ALM events and publications
Continue reading by getting started with a subscription.